Related Experiment Video
Updated: Jun 14, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all
Thomas E Callis1, Brian C Jensen, Karen E Weck
1PGxHealth Division, Clinical Data, Inc., 5 Science Park, New Haven, CT 06511, USA.
Insights
Familial cardiomyopathies stem from gene mutations and are increasingly diagnosed via genetic testing. This review covers genetic causes, testing utility, and future challenges in diagnosing these heart conditions.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiomyopathies are common, heterogeneous cardiac diseases with significant familial prevalence.
- Many cardiomyopathies, including hypertrophic, dilated, and arrhythmogenic right ventricular types, follow Mendelian inheritance patterns due to single-gene mutations.
- The advent of clinical genetic testing necessitates a comprehensive understanding of cardiomyopathy genetics.
Purpose of the Study:
- To review the genetic underpinnings of selected cardiomyopathies.
- To describe the clinical utility and application of genetic testing in cardiomyopathy diagnosis.
- To outline current challenges and emerging advancements in the field of cardiomyopathy genetics and diagnostics.
Main Methods:
- Literature review focusing on genetic basis of cardiomyopathies.
- Analysis of clinical utility of genetic testing for familial cardiomyopathies.
- Synthesis of current challenges and future developments in cardiomyopathy diagnostics.
Main Results:
- Identified specific gene mutations responsible for various inherited cardiomyopathies.
- Highlighted the diagnostic and clinical management benefits of genetic testing.
- Discussed limitations and ongoing progress in genetic diagnostics for cardiomyopathies.
Conclusions:
- Genetic testing is crucial for diagnosing and managing familial cardiomyopathies.
- Continued research is needed to address challenges and leverage emerging developments in the field.
- Understanding genetic etiology improves patient care and family screening for cardiomyopathies.
Abstract:
Cardiomyopathies are an important and heterogeneous group of common cardiac diseases. An increasing number of cardiomyopathies are now recognized to have familial forms, which result from single-gene mutations that render a Mendelian inheritance pattern, including hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and left ventricular noncompaction cardiomyopathy. Recently, clinical genetic tests for familial cardiomyopathies have become available for clinicians evaluating and treating patients with these diseases, making it necessary to understand the current progress and challenges in cardiomyopathy genetics and diagnostics. In this review, we summarize the genetic basis of selected cardiomyopathies, describe the clinical utility of genetic testing for cardiomyopathies and outline the current challenges and emerging developments.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis II: Clinical Features and Diagnostic Tests
